Login / Signup

Post-marketing surveillance of quetiapine fumarate extended-release tablets in patients with bipolar depression.

Taro KishiNakao IwataHiroyuki IrieMasaru Aikawa
Published in: Neuropsychopharmacology reports (2024)
The efficacy of quetiapine fumarate extended-release tablets was confirmed in clinical practice, and no new safety concerns or risks were identified.
Keyphrases
  • clinical practice
  • public health
  • depressive symptoms
  • bipolar disorder
  • human health
  • sleep quality
  • risk assessment
  • physical activity
  • climate change